Back
AbbVie Quote, Financials, Valuation and Earnings
Sponsored
ABBV
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
40
ABBV
AbbVie
Last Price:
159.59
Seasonality Move:
2.71%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.AbbVie Price Quote
$159.59
-0.03 (-4.6%)
(Updated: April 27, 2024 at 4:17 AM ET)
AbbVie Key Stats
Sell
40
AbbVie (ABBV)
is a Sell
Day range:
$157.65 - $167.46
52-week range:
$130.96 - $182.89
Dividend yield:
3.8%
P/E ratio:
58.68
P/S ratio:
5.21
P/B ratio:
27.22%
Volume:
10.6M
Avg. volume:
6.1M
1-year change:
-1.35%
Market cap:
$282B
Revenue:
$54.3B
EPS:
$2.73
How Much Does AbbVie Make?
Is AbbVie Growing As A Company?
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
-
Is AbbVie Stock Overvalued?
AbbVie is trading at a price to free cash flow ratio of 12.83 -
Is AbbVie Stock Undervalued?
AbbVie EV to Free Cash Flow ratio is 14.89 -
What Is AbbVie’s Price Earnings Growth Ratio?
ABBV PEG ratio is 0.00 -
Is AbbVie Trading At A Premium To Earnings?
AbbVie EV to EBIT ratio is 38.77
Is It Risky To Buy AbbVie?
Is AbbVie Cash Flow Positive?
AbbVie Return On Invested Capital
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?
A single share of ABBV can be purchased today for 159.62 -
What Is AbbVie’s Stock Symbol?
AbbVie trades on the S&P500 under the ticker symbol: ABBV -
When Is AbbVie’s Next Earnings Date?
The next quarterly earnings date for AbbVie is scheduled on July 26, 2024 -
When Is ABBV's next ex-dividend date?
AbbVie's next ex-dividend date is April 12, 2024 -
How To Buy AbbVie Stock?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -66.67% | 2.18% |
Revenue: | -5.42% | 3.14% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 13 |
Sell Recommendations: | 0 |
Price Target: | 183.73 |
Upside from Last Price: | 15.1% |